Home » Reports » Broker Ratings » Oxford BioMedica plc 7.2% Potential Upside Indicated by Jefferies International

Oxford BioMedica plc 7.2% Potential Upside Indicated by Jefferies International

Oxford BioMedica plc using EPIC/TICKER code (LON:OXB) has had its stock rating noted as ‘Reiterates’ with the recommendation being set at ‘HOLD’ this morning by analysts at Jefferies International. Oxford BioMedica plc are listed in the Health Care sector within UK Main Market. Jefferies International have set a target price of 725 GBX on its stock. This would imply the analyst believes there is now a potential upside of 7.2% from today’s opening price of 676.33 GBX. Over the last 30 and 90 trading days the company share price has increased 1.73 points and decreased 37.07 points respectively. The 1 year high stock price is 1064.38 GBX while the 52 week low for the stock is 511 GBX.

Oxford BioMedica plc has a 50 day moving average of 678.90 GBX and the 200 Day Moving Average price is recorded at 797.39. There are currently 66,129,701 shares in issue with the average daily volume traded being 65,063. Market capitalisation for LON:OXB is £446,309,368 GBP.